MUMBAI, India, July 7 -- Intellectual Property India has published a patent application (202641058002 A) filed by Saveetha Institute Of Medical And Technical Sciences on May 07, 2026, for Wound Healing Potential Of C- Biocare - Dfu Spray For Diabetic Patients.
Inventors include Dr. Chella Perumal Palanisamy; Dr. Kaliyamoorthy Dass; Pavithra S; Dr. Gopalakrishnan Velliyur Kannlappan; Dr. Selvaraj Jayaraman; Dr. Rajkumar Thamarai; Dr. Venkatesan Karthick; Dr. Nisha B; and Dr. Deepak Nallaswamy Veeraiyan.
The application for the patent was published on July 03, 2026, under issue no. 27/2026.
Abstract: The present invention discloses a spray-based topical formulation designated as C-BioCare- DFU spray developed for diabetic wound healing application. The formulation comprises an aqueous extract of Gracilaria corticatci incorporated into a biopolymeric matrix formed by chitosan and alginate, along with pharmaceutically acceptable stabilizing agents. The ionic interaction between chitosan and alginate results in formation of a structured polymeric network that facilitates sustained release of marine-derived bioactive constituents. The developed formulation demonstrates antioxidant activity, antimicrobial efficacy against wound-associated microorganisms, and cytocompatibility in skin cell models under in vitro conditions. The spray delivery system ensures uniform wound surface coverage and maintenance of a moist microenvironment. The invention provides a stable and scalable therapeutic platform suitable for diabetic wound care.
Disclaimer: Curated by HT Syndication.
